Compare TOWN & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOWN | XENE |
|---|---|---|
| Founded | 1998 | 1996 |
| Country | United States | Canada |
| Employees | 2976 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.2B |
| IPO Year | N/A | 2014 |
| Metric | TOWN | XENE |
|---|---|---|
| Price | $35.94 | $54.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $68.55 |
| AVG Volume (30 Days) | 368.8K | ★ 781.0K |
| Earning Date | 04-22-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $35.63 | N/A |
| Revenue Next Year | $5.18 | $2,496.48 |
| P/E Ratio | $16.23 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.91 | $28.19 |
| 52 Week High | $37.86 | $62.91 |
| Indicator | TOWN | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 60.57 | 45.16 |
| Support Level | $34.69 | $52.55 |
| Resistance Level | $37.22 | $56.66 |
| Average True Range (ATR) | 0.83 | 1.72 |
| MACD | 0.01 | -0.80 |
| Stochastic Oscillator | 69.19 | 19.06 |
Towne Bank is a financial services company serving individuals, commercial enterprises and professionals, offering retail and commercial banking services in Virginia and North Carolina. The company has four reportable segments: Banking, which provides loan and deposit services, commercial mortgage brokerage, and investment and asset management services; Mortgage, which originates mortgage loans principally sold in the secondary market through purchase commitments from investors; Resort Vacation Management, which provides residential resort property management services; and Insurance, which provides property, casualty, life and health insurance solutions for businesses, individuals and community organizations through a variety of carriers.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.